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ABSTRACT
BreCAN-DB (http://brecandb.igib.res.in) is a repos-
itory cum browser of whole genome somatic DNA
breakpoint profiles of cancer genomes, mapped at
single nucleotide resolution using deep sequenc-
ing data. These breakpoints are associated with
deletions, insertions, inversions, tandem duplica-
tions, translocations and a combination of these
structural genomic alterations. The current release
of BreCAN-DB features breakpoint profiles from 99
cancer-normal pairs, comprising five cancer types.
We identified DNA breakpoints across genomes us-
ing high-coverage next-generation sequencing data
obtained from TCGA and dbGaP. Further, in these
cancer genomes, we methodically identified break-
point hotspots which were significantly enriched
with somatic structural alterations. To visualize
the breakpoint profiles, a next-generation genome
browser was integrated with BreCAN-DB. Moreover,
we also included previously reported breakpoint pro-
files from 138 cancer-normal pairs, spanning 10 can-
cer types into the browser. Additionally, BreCAN-DB
allows one to identify breakpoint hotspots in user
uploaded data set. We have also included a function-
ality to query overlap of any breakpoint profile with
regions of user’s interest. Users can download break-
point profiles from the database or may submit their
data to be integrated in BreCAN-DB. We believe that
BreCAN-DB will be useful resource for genomics sci-
entific community and is a step towards personalized
cancer genomics.
INTRODUCTION
It is widely understood that incidence of structural genomic
alterations (GAs) is frequently associated with cancer and
indeed has been posed as a prominent cause for acqui-
sition of hallmarks of cancer initiation/progression (1,2).
These GAs could be large-sized deletions, insertions, in-
versions, translocations, fusions and copy number varia-
tions (3–5). Studies indicate that GAs not only account for
larger genomic heterogeneity in populations but may also
have a much larger than anticipated impact on oncogenesis
and cancer progression (6,7). Most studies so far have fo-
cusedmainly upon association ofmutations, especially non-
synonymous point mutations present in the coding regions
of the genome. Results from such studies have shown that
though certain point mutation events in cancer are more
associated with specific genes like BRCA1 in breast cancer
(8), TP53 in glioblastoma multiforme (9), such mutations
are present in only a small percentage of disease cases (10).
This has led to an increased interest in large-sizedGAs (that
may span from tens of bases to few megabases of genome)
to better understand cancer etiology.
Profiling GAs have been more challenging than profiling
point mutations, mainly due to requirement of deep cov-
erage genome sequence data and algorithms that can map
sequence reads to identify breakpoints at single base res-
olution. With fulfilment of these requirements, various ef-
forts to elucidate the role of GAs in cancer genome have
been made. However, they were unable to include either
large sample size, single base resolution or/and accessible
data for individual breakpoint profile. With these features
in mind, BreCAN-DB was developed to allow users navi-
gate genomes for mining individualized single base resolu-
tion breakpoint events in a readily scalable setting.
Recent studies involvingmeta-analysis of large-scale data
sets have indicated the utility of integrating and method-
ologically making statistical analysis to gain biological in-
sights; these span from analysis of structural variants at
low resolution, gene expression and small RNA expression
(11–13). Moreover, in last few years, various prominent re-
sources have been developed such as COSMIC (14), The
Cancer Genome Atlas (TCGA) data portal (https://tcga-
data.nci.nih.gov/tcga/), UCSC Cancer Genomics Browser
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(15) and International CancerGenome consortium (ICGC)
data portal (16), serving data related to genomic variations
in cancer both as pooled datasets as well as at personal-
ized level. Of these, COSMIC uses a gene-focused approach
wheremostmutation data are available for genes nominated
fromCancerGeneCensus (17) while TCGAand ICGCpro-
vide genomic SNP and copy number profiles at personal-
ized level. BreCAN-DB complements these databases by
adopting an individual profile-based approach for large-
sized GAs over gene-based approach, so that information
on low recurrence but potentially relevant events is retained.
It is being increasingly appreciated to understand genome
in a personalized context. Also, many of the genomic vari-
ations have already been associated with response to ther-
apy while many others still remain elusive (18). Hence, it is
crucial that each cancer’s structural variation is studied in-
dividually so that viable targets for precision therapy may
be developed.
To facilitate studies involving DNA breakpoints at per-
sonalized levels, we have made BreCAN-DB: ‘BREakpoint
profiles of CANcer genomes DataBase’, a browsable repos-
itory of personalized cancer DNA breakpoint profiles
mapped over the entire genomes of 99 cancer and matched
control pairs from five cancer types viz. glioblastoma multi-
forme (GBM), breast invasive carcinoma (BRC), lung ade-
nocarcinoma (LUAD), ovarian serous cystadenocarcinoma
(OV) and head and neck squamous cell carcinoma (HN).
We also provide functionality of visualizing and comparing
DNA breakpoint profiles between samples of same cancer
type or across different cancer types using BreCAN-DB.
MATERIALS AND METHODS
Implementation
BreCAN-DB has been implemented in three phases: Phase
1- collection of whole genome sequencing data of can-
cer and matched normal tissues, Phase 2- mapping of so-
matic DNA breakpoint profiles and breakpoint hotspots
and Phase 3- user interface development for interactive vi-
sualization through web browser. These three phases are de-
scribed below.
Data collection
To generate DNA breakpoint profiles, we retrieved the Il-
lumina whole genome paired end sequencing reads from
99 cancer-normal pairs comprising five cancer types viz. 15
pairs of BRC from Banerji et. al (19), 27 pairs of GBM (9),
17 pairs of LUAD (20), 23 pairs of OV (21) and 17 pairs of
HN (22) from The Cancer Genome Atlas (phase 1 of Fig-
ure 1A). Sequencing data for GBM, LUAD, OV and HN
were downloaded in the BAM format (23), while data for
BRC were downloaded in SRA (sequence read archive) for-
mat from the database of Genotypes and Phenotypes (24)
(dbGaP Study Accession: phs000369 and phs000178). The
paired-end sequencing reads of BRC were aligned to the
human reference genome (UCSC build hg19) using BWA
aligner with default parameters to create BAM files (25).
Further, we also incorporated data of 138 cancer genomes
from Yang et al. where breakpoints were called on cancer
genomes using Meerkat (26).
Mapping of breakpoint profiles
Breakpoints of GAs were identified in all normal and can-
cer genomes independently using Meerkat with default pa-
rameters (26). The algorithm of Meerkat calls GAs at po-
sitions where cluster of read pairs are discordant and sub-
sequently, the breakpoints of these GAs are precisely de-
termined at single nucleotide resolution using soft-clipped
reads. These GAs include insertions, deletions, intra and
inter-chromosomal translocations, inversions, tandem du-
plications and combination of events. To reduce the num-
ber of false positives, we filtered GAs, supported by at least
two discordant pairs and two soft-clipped reads (phase 2
of Figure 1A). GAs with size more than 10 Mb were also
filtered out to get a final list of high confidence GAs. GAs
specifically present in only cancer genomes (somatic GAs)
were identified by subtracting GAs of all normal genomes
from each cancer genome using Meerkat. Further, these
GAs were filtered using Database of Genomic Variants (27)
to get list of only cancer-specific GAs.
Mapping of breakpoint hotspots
To identify DNA breakpoint hotspots, we extended break-
points of each cancer-specific GA by 10 Kb upstream
and downstream (phase 2 of Figure 1A). Further, using
boundaries of extended breakpoint regions from all can-
cer genomes, we segmented the reference genome into non-
overlapping bins of unequal sizes. The bins that overlapped
with extended regions in more than one cancer genome
were identified and their enrichment score was calculated
as number of samples harbouring extended breakpoint re-
gions overlapping with these bins. Next, we compared these
scores with expected distribution of score calculated by ran-
domizing theGAs of all samples 10000 times and calculated
their significance. The bins with P-value <0.05 after Bon-
ferroni Hochberg correction for multiple hypothesis testing
were finally selected as cancer breakpoint hotspots. Simi-
lar strategy was used to find breakpoint hotspots for all five
types of cancer separately.
Development of web-accessible interface
The interactive front end interface of database was designed
usingHTML, CSS and JavaScript andmade web-accessible
through Apache2 HTTP server running on CentOS7 Linux
platform (phase 3 of Figure 1A). The server is hosted at
Institute of Genomics and Integrative Biology and can be
accessed at http://brecandb.igib.res.in. For visualization of
breakpoint profiles in BreCAN-DB, these breakpoint pro-
files were converted to json format and integrated with
JBrowse, an advanced, open source and JavaScript-based
genome browser (28,29). JBrowse uses an approach where
most feature rendering is done by the client machine rather
than server, resulting in quick response to the user. Further,
other modules to submit and download breakpoint profiles
in BED format were implemented using PHP. The modules
‘Compare Breakpoint profiles’ to compare a new genomic
profile against breakpoint profiles of database and ‘Map
Breakpoint hotspots’ to map breakpoint enriched regions
were implemented usingBEDTools (30) and the former out-
puts sortable barplots, implemented using D3.js (31).
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RESULTS
Database content and statistics
BreCAN-DB is DataBase of personalized somatic DNA
BREakpoint profiles of CANcer genome. The current ver-
sion of the database comprises whole genome somatic
breakpoint profiles of 99 cancer-normal pairs from five
types of cancer obtained from The Cancer Genome At-
las and dbGaP (19). The raw breakpoints were mapped
at single nucleotide resolution in cancer genome deep se-
quencing data usingMeerkat software (26), which were fur-
ther filtered using GAs from corresponding cancer type
pooled normal data and Database of Genomic variants
(27) (see Methods; Figure 1A). These profiles were named
as GBM profile1 to GBM profile27 for 27 breakpoint
profiles of GBM, BRC profile1 to BRC profile15 for 15
BRC, LUAD profile1 to LUAD profile17 for 17 LUAD,
OV profile1 to OV profile23 for 23 OV and HN profile1
to HN profile15 for 15 HN as shown in Figure 1B.
These DNA breakpoints correspond to large-sized dele-
tions, tandem duplications, insertions, inversions, intra and
inter-chromosomal translocations and combination of such
events. A total of 1 92 626 breakpoints were identified with
average number of 1945 breakpoints per cancer genome.
Table 1 provides the number of breakpoints in different
cancer genomes. Further, we have also mapped significant
breakpoint hotspots in five different types of cancer, i.e. ge-
nomic regions with more number of observed DNA break-
points in comparison to expected (seeMethods; Figure 1A).
BreCAN-DB also collates 4415 breakpoint hotspots dis-
tributed over the whole genome (see Table 2). Further, we
included 138 whole genome breakpoint profiles from 10
cancer types mapped by Yang et al. (26). This data set in-
cluded three cancer types already present in our analysis viz.
breast invasive carcinoma (BRCA; n = 35), glioblastoma
multiforme (GBM; n = 16) and ovarian serous cystadeno-
carcinoma (OV; n= 9); beyond these it included seven other
cancer types viz. colorectal adenocarcinoma (CRC; n= 14),
multiple myeloma (MM; n = 7), prostrate adenocarcinoma
(PR; n = 7), hepatocellular carcinoma (HCC; n = 19), lung
squamous cell carcinoma (LUSC; n = 18), uterine corpus
endometrioid carcinoma (UCEC; n = 10) and kidney renal
clear cell carcinoma (KIRC; n = 3).
Apart from serving as repository, we have included five
modules in BreCAN-DB that help users analyse their own
data with breakpoints present in the database. These five
modules are ‘Breakpoint Profiles and hotspots browser’,
‘Map Breakpoint hotspots’, ‘Compare Breakpoint Pro-
files’, ‘Submit Breakpoint Profiles’, ‘Download Breakpoint
Profiles’ (Figure 1C), these have been discussed further in
the following sections.
Breakpoint Profiles and hotspots browser
To visualize the distribution of DNA breakpoint profiles of
cancer genomes, we provided a genome browser as shown
in Figure 2A. The browser tracks have been divided into
mainly three sections. Section 1 contains the tracks of
human reference genome (assembly hg19), chromosome
bands andRefseq genes downloaded fromUCSC. Section 2
contains five tracks, each representing breakpoint hotspots
(see Methods for details) for one type of cancer. Section 3
contains tracks of personalized whole genome breakpoint
profiles, each representing breakpoint profile of a sample
from particular cancer type. A separate tab was created in
this section to include data from external sources (currently
from Yang et al.).
The views are available from chromosome level to nu-
cleotide level. For better visualization, each DNA break-
point in breakpoint profile tracks has been shown as rect-
angular bar representing a 20 Kb region centralized at the
breakpoint. Moreover, information on chromosome band-
ing is also provided as separate track. Any of these tracks
can be switched on or off by user for interactive visualiza-
tion. The genomic sequence of hotspots and breakpoints
can also be obtained by clicking on the respective feature.
Also, we have annotated each breakpoint such that its as-
sociated genomic alteration type is directly visible to the
user. It also allows user to upload breakpoint profiles in
Browser Extensible (BED) format (a flexible format that al-
lows features to be represented in form of genomic start
and end coordinates) and visualize it along with one or
more selected profiles already available in the database. In
this way, user can directly compare whether the uploaded
breakpoints overlap with his gene of interest or breakpoint
hotspots or breakpoint profile of any of the five types of
cancer.
Map breakpoint hotspots
We also provide a module wherein user can submit DNA
breakpoint profiles of multiple samples and obtain break-
point hotspots, regions with breakpoints inmore than given
number of samples (Figure 2B). The breakpoint profiles in
BED format must be zipped with one file per sample and
uploaded to the module. These breakpoints should be pro-
vided at nucleotide base resolution as this module first ex-
tends each breakpoint by 10Kb upstream and downstream.
Next, it divides the human genome into non-overlapping
bins of unequal sizes using boundaries of extended regions
and finds bins that overlap with more than threshold num-
ber (given by user) of samples. The output file contains ge-
nomic coordinates of breakpoint hotspots along with num-
ber of samples having overlap of extended regions.
Compare breakpoint profiles
One of the important modules of BreCAN-DB allows one
to compare user-uploaded new breakpoint profiles against
hotspots or individual profiles already present in database
(Figure 2C). The breakpoint profiles can either be uploaded
as a file from local machine or paste in BED format. User
can select type of cancer against which given breakpoint
profile will be compared. On submitting data, module re-
ports number of overlapping breakpoints with the hotspots
and with the breakpoint profiles as sortable bar plots.
Submit breakpoint profiles
For further populating the database, we have included a
module wherein user can submit whole genome breakpoint
profiles of different cancer genomes which will be made
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Figure 1. (A) Three phases for the development of BreCAN-DB: Phase 1- collection of whole genome sequencing data from cancer and matched normal
tissues; Phase 2- mapping of breakpoint profiles and breakpoint hotspots; and Phase 3- designing a web-accessible and interactive user interface. (B) Pie
chart representing number of cancer-normal pairs in five types of cancer. (C) Five modules in BreCAN-DB.
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Figure 2. (A) A view of ‘Breakpoint Profiles and hotspots Browser’ module in BreCAN-DB representing tracks of overlapping genes, breakpoint profiles
and hotspots. The tracks in browser are divided into three sections: Section 1- tracks of human reference genome assembly hg19, chromosome bands and
Refseq genes; Section 2- tracks of breakpoint hotspots. Each rectangular bar in these tracks represents one breakpoint hotspot; and Section 3- tracks of
individual breakpoint profiles. Each rectangular bar in these tracks represents a 20 Kb region centralized at the breakpoint position. (B) ‘Map Breakpoint
hotspots’ module takes breakpoint profiles as input and maps regions with breakpoint in at least given number of samples. (C) ‘Compare Breakpoint
Profiles’ module compares user provided breakpoint profile against breakpoint hotspots and profiles present in the database and shows overlaps in the
form of sortable bar plots.
Table 1. Summary of data sets used
Cancer type Source
Number of
cancer-normal pairs
Number of
Breakpoints
Number of breakpoints
per cancer genome
Glioblastoma multiforme (GBM) TCGA (9) 27 pairs 55 874 2069
Breast invasive carcinoma (BRC) Banerji et al. (19) 15 pairs 22 077 1471
Lung adenocarcinoma (LUAD) TCGA (20) 17 pairs 36 086 2122
Ovarian serous cystadenocarcinoma (OV) TCGA (21) 23 pairs 56 435 2453
Head and neck squamous cell carcinoma (HN) TCGA (22) 17 pairs 22 154 1303
Total 99 pairs 1 92 626 1945
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Table 2. Summary of breakpoint hotspots
Cancer type
Number of
hotspots
Length of genomic
region (Mb)
GBM 839 36
BRC 759 31
LUAD 846 37
OV 990 45
HN 981 43
Total 4415 192
open for scientific community after curation.While submit-
ting such profiles, we request submitters to describe meth-
ods to map breakpoints clearly in order to reduce method
dependent biasing of the results.
Download breakpoint profiles
We also provide a ‘Download’ module to download all the
99 whole genome breakpoint profiles in BED format. This
will be useful for users who want to locally run analysis
through integrating BreCAN-DB data sets with their own
data.
CONCLUSION AND FUTURE DEVELOPMENTS
Each cancer genome has unique set of structuralGAs, SNPs
and other genomic variations and keeping this in mind,
BreCAN-DB has been developed as a unique database that
not only allows user to visualize individual DNA break-
point profiles across cancer types but also perform compar-
ative study of their samples against existing data. Through
BreCAN-DB, we provide a platform that is readily scal-
able for further sample’s data and allows study of somatic
DNA personalized breakpoint at single nucleotide resolu-
tion. In summary, we have first developed a curated data
set representing high-resolution breakpoint profiles for 99
cancer-normal pairs. Secondly, we systemically identified
hotspot regions across cancer types using a novel strategy.
Thirdly, we made these data accessible through an inte-
grated next-generation genome browser. Fourthly, we cre-
ated a platform, where users can perform comparative can-
cer genomics by checking intersection between their and
BreCAN-DB data sets. These data sets can easily be ex-
tended by addition of more breakpoint profiles requiring
no additional analyses or change in existing data sets as
demonstrated through inclusion of data set from Yang et
al. (26).
In our data set, we noted that the mean number of break-
points were higher than previously reported (26). Since we
used the same software as used in previous study (Meerkat)
for profiling breakpoints, it is unlikely that this difference
is due to methodology of mining breakpoints. Rather, we
speculate that this might be a sample specific effect as the
number of breakpoints was variable across samples in both
studies. Furthermore, we found that the average number of
genomic alterations in our study (excluding translocations
and inversions) were similar to the ones noted earlier (this
study did not report translocations and inversions) (32).
We request users to help scientific community by submit-
ting such breakpoint profiles from their study to BreCAN-
DB. We believe that this database will prove useful for un-
derstanding large-scale personal cancer genomics data.
AVAILABILITY
The database is freely available at http://brecandb.igib.res.
in.
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